Richard Delorme is head of the Center of Excellence for Autism Spectrum Disorders and Neurodevelopmental Disorders (InovAND) and head of the Department of Child and Adolescent Psychiatry at the Robert Debré Hospital, both in Paris, France. He has a broad background in child psychiatry and genetics, with expertise in the identification of biomarkers in rare diseases associated with autism. He is also a researcher at the Human Genetics and Cognitive Functions Laboratory at the Institut Pasteur, in Paris. In recent years, he has been involved in several research programs, brain imaging studies and IPSC-based drug screening technology. He is an author on more than 100 publications.
Richard Delorme
Head
Center of Excellence for Autism Spectrum Disorders and Neurodevelopmental Disorders
From this contributor
Coronavirus tool kit may aid families with autistic children during lockdown
To help families cope with the sudden loss of professional support during the pandemic, one team in France has created a set of resources and information.
Coronavirus tool kit may aid families with autistic children during lockdown
By
Richard Delorme, Benjamin Landman
21 April 2020 | 4 min read
Explore more from The Transmitter
Can AI do neuroscience without understanding?
Prediction without understanding sustained astronomy through a thousand years of epicycles. Artificial intelligence is now offering neuroscience the same deal.
Can AI do neuroscience without understanding?
Prediction without understanding sustained astronomy through a thousand years of epicycles. Artificial intelligence is now offering neuroscience the same deal.
By
Anthony Zador
27 April 2026 | 6 min read
What Trump’s psychedelics executive order means for basic neuroscience
The order provides a potential path to remove some psychedelic drugs from the strictest regulatory category, yet it “may not be the breakthrough the basic research community has been looking for,” says neuroscientist Shawn Lockery.
What Trump’s psychedelics executive order means for basic neuroscience
The order provides a potential path to remove some psychedelic drugs from the strictest regulatory category, yet it “may not be the breakthrough the basic research community has been looking for,” says neuroscientist Shawn Lockery.
By
Calli McMurray
24 April 2026 | 4 min read
Switching neural code may solve ongoing face-recognition debate
Face patch cells in macaque monkeys initially respond to images of any object but rapidly transition to attend to faces exclusively, a new study finds.
Switching neural code may solve ongoing face-recognition debate
Face patch cells in macaque monkeys initially respond to images of any object but rapidly transition to attend to faces exclusively, a new study finds.
By
Holly Barker
23 April 2026 | 5 min read